clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
Cytokine TV: Implantable Protein Sensors Monitor Live Inflammation
News & Features
Rate of Personalized Cancer Treatment Rising
Molecular Dx
Abnormal or Non-Reportable NIPT Can Help Detect Cancer During Pregnancy
Molecular Dx
Point-of-Care Imaging Tests Show Promise in Identifying Early Sepsis for Treatment
News & Features
Women Pay for AI-Enhanced Mammography
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Lloyd Sanders Named New CEO of Epic Sciences
Epic Sciences
News & Features
Lloyd Sanders Named New CEO of Epic Sciences
March 26, 2019
0
Molecular Dx
Epic Sciences, Genomic Health Get Medicare LCD for Prostate Cancer Diagnostic
October 29, 2018
0
Molecular Dx
Study Shows Epic Sciences Liquid Biopsy Aids Prostate Cancer Patient Selection
September 24, 2018
0
Molecular Dx
Epic Sciences Adds Analyses to Enhance Patient Selection for Cancer Immunotherapies
November 3, 2017
0
Molecular Dx
With $40M in Financing, Epic Sciences to Advance Liquid Biopsy Cancer Tests
May 1, 2017
0
Related Content
Rate of Personalized Cancer Treatment Rising
Abnormal or Non-Reportable NIPT Can Help Detect Cancer During Pregnancy
Breaking New Ground in Immunology & Inflammation
Improving Precision Oncology
Inside Precision Medicine
![Epic Sciences said today its liquid biopsy blood test showed in a study that it can help physicians select prostate cancer patients who are likely to benefit from a Pfizer prostate-specific membrane antigen (PSMA)-targeted therapy candidate known as BIND-014 before the start of treatment. [Source: © Alex Tihonov/Fotolia]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1907.jpeg "Study Shows Epic Sciences Liquid Biopsy Aids Prostate Cancer Patient Selection")
